Bristol-Myers Squibb Co (BMY)
44.71
-0.35
(-0.78%)
USD |
NYSE |
May 14, 16:00
44.96
+0.25
(+0.56%)
Pre-Market: 06:16
Bristol-Myers Squibb Gross Profit Margin (Quarterly): 75.29% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 75.29% |
December 31, 2023 | 76.08% |
September 30, 2023 | 77.15% |
June 30, 2023 | 74.38% |
March 31, 2023 | 77.37% |
December 31, 2022 | 77.27% |
September 30, 2022 | 79.02% |
June 30, 2022 | 77.12% |
March 31, 2022 | 78.79% |
December 31, 2021 | 80.34% |
September 30, 2021 | 80.29% |
June 30, 2021 | 79.05% |
March 31, 2021 | 74.34% |
December 31, 2020 | 73.71% |
September 30, 2020 | 76.26% |
June 30, 2020 | 73.35% |
March 31, 2020 | 66.03% |
December 31, 2019 | 68.63% |
September 30, 2019 | 70.20% |
June 30, 2019 | 68.56% |
March 31, 2019 | 69.19% |
December 31, 2018 | 73.05% |
September 30, 2018 | 71.04% |
June 30, 2018 | 71.51% |
March 31, 2018 | 69.50% |
Date | Value |
---|---|
December 31, 2017 | 70.62% |
September 30, 2017 | 69.95% |
June 30, 2017 | 69.50% |
March 31, 2017 | 74.34% |
December 31, 2016 | 73.18% |
September 30, 2016 | 73.49% |
June 30, 2016 | 75.24% |
March 31, 2016 | 76.04% |
December 31, 2015 | 77.79% |
September 30, 2015 | 73.04% |
June 30, 2015 | 75.67% |
March 31, 2015 | 79.04% |
December 31, 2014 | 77.31% |
September 30, 2014 | 74.32% |
June 30, 2014 | 74.52% |
March 31, 2014 | 74.60% |
December 31, 2013 | 71.34% |
September 30, 2013 | 71.09% |
June 30, 2013 | 72.63% |
March 31, 2013 | 72.25% |
December 31, 2012 | 74.35% |
September 30, 2012 | 73.58% |
June 30, 2012 | 71.98% |
March 31, 2012 | 75.19% |
December 31, 2011 | 74.94% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
66.03%
Minimum
Mar 2020
80.34%
Maximum
Dec 2021
75.16%
Average
76.17%
Median
Gross Profit Margin (Quarterly) Benchmarks
Amgen Inc | 57.03% |
Gilead Sciences Inc | 76.79% |
Johnson & Johnson | 69.55% |
Eli Lilly and Co | 80.91% |
2seventy bio Inc | 63.82% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -22.11% |
Return on Assets | -6.50% |
Return on Invested Capital | -8.84% |
Profit Margin (Quarterly) | -100.4% |
Operating Margin (Quarterly) | 12.76% |
Return on Net Operating Assets | -7.92% |